Expression of androgen-activating enzymes in cultured cells of developing rat brain by A. Poletti et al.
Journal ofNeurochemistry
Lippincott—Raven Publishers, Philadelphia
© 1997 International Society for Neurochemistry
Expression of Androgen-Activating Enzymes in Cultured
Cells of Developing Rat Brain
Angelo Poletti, Paola Negri-Cesi, Roberto Cosimo Melcangi, Alessandra Colciago,
Luciano Martini, and Fabio Celotti
Istituto di Endocrinologia, Università di Milano, Milano, Italy
Abstract: Dihydrotestosterone and estradiol, two active
metabolites formed locally in the brain from testosterone,
modulate several functions of the developing rat CNS;
these compounds derive from the 5cs-reduction or the
aromatization of the A-ring of the hormone. Also, proges-
terone and corticosteroids may be 5a-reduced and sub-
sequently 3a-hydroxylated, becoming modulators of spe-
cific neuronal functions. Although the aromatase is a sin-
gle enzyme, two typesof 5a-reductase have been cloned,
showing peculiar biochemical properties and probably
different functions. Therefore, the isoform(s) of the en-
zyme 5a-reductase(s) present in early stage of brain de-
velopment have been characterized in primary neuronal
and glial cell cultures obtained from the fetal or neonatal
rat brain, respectively. Aromatase expression was also
studied. The results have shown that in all the brain cells
examined type 1 5cs-reductase mRNA is expressed. No
specific transcript of type 2 5a-reductase is detectable
in any of the cell types examined. Finally, the aromatase
gene is expressed only in cultured fetal neurons and es-
pecially in those derived from the hypothalamic area of
the rat embryos. It is interesting that no aromatase mRNA
is detectable in mixed glia or in type 1 astrocytes and
oligodendrocytes cultured separately. Key Words: An-
drogens — 5cr - Reductases — Aromatase — Neurons —
Glial cells—Rat brain.
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Hormonal steroids are known to modulate several
CNS functions. For instance, androgens appear to be
responsible for the control of the sexual differentiation
of the brain as well as of adult male sexual behavior;
progesterone and deoxycorticosterone, in high doses,
may exert anxiolytic and anesthetic properties (Paul
and Purdy, 1992). It has been demonstrated that some
of these actions may be mediated by steroid meta-
bolites, rather than by the hormones themselves. The
sexual differentiation of the brain is linked to the aro-
matization of testosterone to estrogens; the anxiolytic/
anesthetic properties of progesterone and of deoxycor-
ticosterone are due to their respective 5cr-reduced-3a
hydroxylated metabolites, 3cr-hydroxy, 5ct-pregnan-
20-one (allopregnanolone or tetrahydroprogesterone),
and 3a,2 1-dihydroxy-5a-pregnan-20-one (tetrahydro-
deoxycorticosterone) (Negri-Cesi et al., 1996). These
compounds do not bind to classic steroid receptors but
interact with the modulatory subunits of the GABA-
gated Cl channel of the GABAA receptor (Majewska
et al., 1986; Gee eta!., 1988; Majewska, 1992). There-
fore, it is presently believed that the enzymatic com-
plexes responsible for these transformations, respec-
tively, aromatase (Aro) and 5a-reductase (5a-R) 3cr-
hydroxysteroid dehydrogenase system, play significant
roles in regulating brain functions.
5cx-R reduces the double bond in the 4—5 position
of the A-ring of several 3-keto-L~4steroids, e.g., testos-
terone, progesterone, deoxycorticosterone, corticoste-
rone, etc., and is widely distributed in the rat brain
(Celotti et al., 1992). 5a-R activity has been detected
in several brain regions and structures and is particu-
larly high in the white matter and in the myelin (Celotti
et a!., 1992). Moreover, among the various cell types
present in the CNS, this enzymatic activity is much
higher in neurons than in glial cells (oligodendrocytes
and astrocytes) (Melcangi et al., 1993). Recently, two
different isoforms of 5a-R have been cloned (Russell
and Wilson, 1994) and found to possess a limited de-
gree of homology (44%) as well as different biochemi-
cal properties: the pH optima are neutral to alkaline
for the type 1 and acidic (pH 5.5) for the type 2 iso-
form, and the affinity for the various substrates (testos-
terone, progesterone, corticosterone, etc.) is generally
lower for the type 1 than for the type 2 isoform. Type
1 and type 2 isozymes also differ in their tissue and
cellular distribution (Normington and Russell, 1992),
in their subcellular compartmentalization (Poletti et
al., 1996; Span et al., 1996), and in their sensitivity
to inhibitors (Russell and Wilson, 1994). Because of
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these differences, it is expected that the two 5a-R iso-
zymes, even if they catalyze the same reaction, might
exert different physiological functions. Moreover, it is
interesting that the gene expression of the type I 5cr-
R is heterogeneous and may give rise to two forms,
differing in four amino acids in the N-terminal portion
of the molecule; the two subforms of the 5a-R type 1
possess different affinity for the substrates (Lopez-
Solache et al., 1996).
Few data are available on the distribution of the two
5cr-R isozymes in the rat brain. Using in situ hybridiza-
tion techniques, the presence of the rnRNA for the type
1 5a-R has been demonstrated in specific areas of the
rat brain, with three distinct patterns of expression:
during early fetal development type 1 mRNA is ex-
pressed in the proliferatingregion close to the ventricu-
lar wall of the CNS; during late fetal/early postnatal
development, the expression in the ventricular zone
decreases, whereas an increase of type 1 5cx-R expres-
sion is observed in the cortical plate and in the thala-
mus; and finally, in adult life, type 1 5a-R expression
appears to be confined to white matter structures
(Lauber and Lichtensteiger, 1996). These results agree
with the distribution of the activity of the enzyme
found in the rat brain (Poletti et al., 1990; Celotti et
al., 1992) and also with the distribution of the protein
analyzed by immunohistochemistry (Tsuruo et al.,
1996). It is important to note that another recent immu-
nohistochemical study has shown the presence of the
type 1 isozyme in glial cells, and not in neurons (Pel-
letier et al., 1994), in apparent conflict with the fact
already mentioned that enzymatic activity is highest in
neurons (Melcangi et al., 1993). This could suggest
that the enzymatic activity found in neurons might be
the type 2 isoform; however, the expression of the type
2 5a-R in the rat brain is still controversial. Northern
analysis performed on total RNA obtained from the
whole brain of 7-week-old male rats has suggested that
the CNS expresses both forms of the enzyme, with a
greatpredominance of the type 1 isoform (Normington
and Russell, 1992). More recently, using the same
technique, the presence of only type 1 mRNA has been
described in the brain of male rats of the same age
(Lephart, 1993); it must be recalled, however, that
northern analysis is probably not sensitive enough to
exclude the presence of type 2 mRNA and conse-
quently of the enzymatic protein.
The second androgen-activating enzyme, Aro, ap-
pears to be a single enzyme, with the same amino acid
sequence in the different tissues in which it is present,
even if its expression appears to be under the control
of tissue-specific promoters. Studies on the regional
distribution of Aro in the brain have indicated that this
enzyme has a discrete distribution, particularly in the
hypothalamus, the preoptic area, and the limbic sys-
tem, i.e., in structures involved in the control of repro-
ductive functions. Studies on the localization of the
enzyme, performed by assaying the enzymatic activity
in primary cultures of different brain cells (Negri-Cesi
et al., 1992) and by immunohistochemical (Shinoda,
1994) or by in situ hybridization (Lauber and Lichten-
steiger, 1994) techniques on the total rat brain, agree
in indicating that only neurons aromatize androgens;
however, the presence of a small amount of Aro or of
its expression in other CNS cell types has not been
carefully evaluated using the highly sensitive tech-
niques presently available.
The aim of the present study was (a) to characterize
the pH optima of the Scr-R (s) present in primary cell
cultures of neurons and mixed glia obtained from the
fetal or neonatal rat brain, to obtain a possible indica-
tion on the enzyme isoform responsible for such con-
version, and (b) to analyze the expression of the two
types of 5a-Rs and of Aro in the different cell types of
the CNS, using the most powerful technique presently
available, i.e., reverse transcription (RT) —polymerase
chain reaction (PCR).
MATERIALS AND METHODS
Animals
The embryos and the newborn rats were obtained from
Sprague—Dawley mothers (Charles River, Italy) that were
maintained in animal quarters with controlled temperature
and humidity. The light schedule was 14 h of light and 10
h of dark (lights on at 0630 h). The mothers were fed a
standard pellet diet, and water was provided ad libitum.
Cell cultures
Neuronal cells were cultured from total brain of 15-day-
old embryos obtained from time-pregnant mothers (day 0
= sperm-positive smears) as previously described (Mel-
cangi et al., 1993) and were used at 6 days in vitro (div);
hypothalamic neuronal cell cultures were obtained from the
hypothalamic region of the brain of 16-day-old embryos by
dissolving the tissue in Dulbecco’s modified Eagle’s me-
dium. The total cells in suspension were then plated for 1 h
in 10-mm-diameter Petri dishes to remove fibroblast cells
(which adhere rapidly to the plate), and thefloating neurons
were collected and plated on polylysine-coated 35-mm-di-
ameter Petri dishes in phenol red-free Dulbecco’s modified
Eagle’s medium containing 20% fetal calf serum. After 24 h
the medium was replaced with achemically defined medium
(Dulbecco’s modified Eagle’s medium without phenol red
containing 50 U/ml penicillin, 50 U/ml streptomycin, 5 ~zg/
ml bovine insulin, 100 ~.tg/mlbovine transferrin, 100 ,ciM
putrescine, and 20 nM sodium selenite) until the collection
of the cells (5 days div). Mixed glial cell cultures were
obtained from 1- or 2-day-old newborn rats and were used
at 19 div (Melcangi et al., 1993). Type 1 astrocyte cultures
were obtained from mixed glial cultures (at 14 days div) by
shaking the flasks overnight at 37°Cand replating the cells
from the bed layer according to the methods of McCarthy
and DeVellis (1980); the astrocytes were used after 5 div.
Oligodendrocyte cultures were obtained from primary cul-
tures of mixed glia [5 div (Besnard et al., 1989)] and were
used at 6 div (Melcangi et al., 1993).
Assay of the 5ff-R activity
To determine the pH optimum of the enzymatic iso-
form(s) present in the cultured brain cells, the incubations
were performed in phosphate-buffered saline solution (250
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~l) at various pH values (ranging from 4 to 8) in the pres-
ence of an NADPH generating system (Poletti et al., 1990)
and 3 X 106 M [‘4C]testosterone (specific activity, =56.9
mCi/mmol; Amersham, U.K.). Theincubations were carried
out for 2 h at 37°Cin a Dubnoffmetabolic shaker under a
stream of 0
2/C02 (98:2). Vials without tissue provided the
blanks for each pH value, and protein content was evaluated
according to the method of Bradford (1976).
Detection ofmetabolites. At the end of the incubation the
reaction was stopped by freezing the samples to —20°C.
Tritium-labeled dihydrotestosterone (DHT) and 5a-andro-
stane-3a,17/3-diol(3a-diol) (=5,000 dpm each) were added
to each sample to evaluate the recoveries. The metabolites
formed were extracted twice with diethyl ether and separated
by TLC using an eluting mixture of dichloromethane/diethyl
ether (11:1 vol/vol). The total 5a-R activity was expressed
as the sum of the two major testosterone metabolites, DHT
and 3a-diol.
RT-PCR analysis
Oligonucleotide sequences. All the synthetic oligonucleo-
tides were deduced from published sequences of the eDNA
of the two isoforms of 5a-R and of Aro and obtained from
Pharmacia Biotech(Sweden). All the various types of brain
cultured cells were solubilized in guanidium isothiocyanate,
and total RNA was prepared by centrifugation over a 5.7 M
cesium chloride step gradient.
RT and PCR were performed using a GeneAmp kit (Per-
kin Elmer) on 2 j~gof total RNA from each sample. The
same extracts of total RNA were subjected to specific analy-
sis for the presence of 5a-Rl, 5cr-R2, and Aro mRNAs.
Samples of total RNA obtained from both adult rat abdomi-
nal skin and prostate, known to contain high levels of both
5a-Rl and5a-R2 mRNA (Russell and Wilson, 1994), were
used as positive controls for 5a-R isoforms; samples of total
RNA extracted from adult rat ovary, known to contain high
levels of Aro mRNA, or from rat placenta, which does not
express the Aro gene, were used as positive or negative
controls, respectively, for the Aro amplification. The syn-
thetic oligonucleotides used as primers for the amplifications
are schematically reported in Fig. 1, and the nucleotide se-
quences were as follows: for 5a-R 1 amplification, upstream
primer, 5’-CGA CCT GCC TGG TTC ATA CA; down-
stream primer, 5 ‘-GGT CAC CCA GTC TTC AGC AT; for
5a-R 2 amplification, upstream primer, 5 ‘-GTC CTG CTG
GCT CTC TTC TC; downstream primer, 5 ‘-CAG GCT TCC
TGA GCT GGC GC; and for Aro amplification, upstream
primer, 5 ‘-TTG TTG TTA AAT ATG ATG CC; down-
stream primer, 5 ‘-ATA CCA GGT CCT GGC TAC TG
(Bulun et al., 1993). Genomic DNA amplification is avoided
in the three types of analysis performed because of the prop-
erties of the set of primers chosen; those are located on
different exons of each gene (as determined by comparison
of the rat and human sequences alignments). Moreover, the
RNA preparations were assayed in preliminary experiments
in which the RT-PCR was performed omitting the addition
of the reverse transcriptase in the samples. No specific bands
were observed, indicating that genomic DNA could not be
amplified.
The RT conditions were as follows: 42°C for 45 mm
followed by 5 mm at 95°C,using a final concentration of
1 mM each deoxynucleotide triphosphate, 1 U of RNase
inhibitor, 2.5 U of murine leukemia virus reverse tran-
scriptase, and the downstream primer in a final volume of
20 ~.rl.The same buffer (50 mM KC1, 10 mM Tris-HC1, and
2 mM MgC12) was used for both transcription and amplifica-
tion. The final amplification mixture comprised 2.5 U of
Ampli-Taq polymerase (GeneAmp Kit; Perkin-Elmer) and
the upstream primer in a final volume of 100 gil. Samples
were amplified by repeated cycles (35) at 95°Cfor 1 mm,
42°Cfor 1 mm, and 72°Cfor 1 mm.
FIG. 1. Schematic representation of the positions of the three sets of oligoprimers, on the corresponding published cDNA, used in
RT-PCR of the mRNAs of the two 5a-R isoforms and of Are mRNAs.
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Amplification products were separatedby electrophoresms
in 2% agarose gel, which was visualized with ethidium bro-
mide staining. The amplified cDNAs were transferred to a
blotting membrane (Zeta-Probe; Bio-Rad, Richmond, CA,
U.S.A.) by capillary elution in lOx SSC (standard saline
citrate) and fixed by baking at 80°Cfor 2 h under vacuum.
The synthetic oligonucleotides used as radiolabeled probes
in Southern analysis were as follows: Sct-R 1 oligoprobe,
5 ‘-AGC AGA TAC TTG AGC CA; 5a-R 2 olmgoprobe, 5’-
ACA TTA CTT CCA CAG GAC ATT T; and Aro oligo-
probe, 5 ‘-CAC ATA ATG AAG CAC AAT CAT TA. The
labeling reactions were performed on the free 5’ end of the
oligoprimers using T4 DNA polynucleotide kinase and [y-32P1 dATP. The eDNA on the membrane was then incubated
at 45°Cfor 4 h with the prehybridizing solution, added to
the 5 ‘-32P-end-labeled oligonucleotideprobes (1 X 106 cpm/
ml) specific for the cDNAs of the two isoforms of Scr-R and
of Aro, and hybridized at 45°Covernight. After washing the
membranes were exposed to x-ray films.
RT-PCR blanks were performed using distilled water and
simultaneously subjected to RT-PCR—Southern blotting
with the same reagents and conditions described. In any
of the experiments performed no specific signal could be
obtained, indicating that no contamination of any reagents
occurred in these studies.
RESULTS AND DISCUSSION
This first set of experiments was designed to dissect
out which Scr-R isoform(s) are present in the rat brain,
by taking advantage of the different pH optima of the
two Scr-R isoforms; the variation of the enzymatic ac-
tivity of the 5a-R has been analyzed as a function of
thepH (from 4 to 8) in lysates of cultured fetal neurons
and neonatal mixed glia cells, by measuring the for-
mation of labeled DHT and 3cr-diol from [‘4C1-
testosterone. Figure 2 shows the pattern of 5cr-R activ-
FIG. 2. Variation of the 5a-R activity as a function of pH in
cultured rat neurons derived from the brain of embryos at gesta-
tional day 15 and rat mixed glial cells derived from the brain of
newborn animals. Enzymatic activity was measured as pico-
grams per milligram ofprotein oflabeled 5cr-reduced metabolites
formed after incubation of [14C]testosterone,in the presence of
NADPH as cofactor. See Materials and Methods for details.
FIG. 3. Southern analysis performed on the RT-PCR product of
amplification obtained using specific sets of oligoprimers for the
two isoforms of the 5a-R. The amplification was performed on
the total RNA derived from the following samples: lane 1, DNA
markers; lane 2, mixed glial cells; lane 3, type 1 astrocytes; lane
4, oligodendrocytes; lane 5, neurons derived from the whole
brain; lane 6, rat adult ventral prostate; lane 7, rat abdominal
skin; and lane 8, water.
ity in the two types of cell preparations, expressed as
the sum of the amounts of the two 5a-R metabolites
formed per milligram of protein in 2 h of incubation.
The results show that the 5a-R activity present in rat
fetal neurons obtained from total brain and in rat neo-
natal mixed glial cell cultures does not possess a clear-
cut pH dependency, being similarly active at pH values
ranging from 4 to 8; no peak of activity was obtained
for either type of cell culture at acidic pH. Moreover,
at all pH values, fetal neurons in culture possess about
a twofold higher 5a-R activity than mixed glial cell
cultures obtained from newborn rats. These data seem
to assign to the type 1 isoform the reducing activity
present in the cells examined and confirm a previous
finding indicating that neurons possess a 5cr-R activity
higher than that of glial cells (Celotti et al., 1992;
Melcangi et al., 1993). It is noteworthy that the charac-
teristic peak of activity at pH 5.5 of the 5a-R type 2
is absent in both types of cultures; however, the enzy-
matic activity present at pH 4 and 5 probably cannot
be ascribed to the traditional type 1 alone because
under these conditions, when the recombinant enzyme
is expressed in mammalian cells (Normington and
Russell, 1992) or in yeast cells (Poletti et al., 1996),
type 1 activity is reduced to 50% or even more. One
possibility to explain this activity is to postulate the
existence in the rat brain of a subtype of the type 1
5a-R like the one recently described by Lopez-Solache
et al. (1996), which is an elongated form (four amino
acids in the N-terminal region) derived from the same
gene. Another possibility is the hypothesized existence
of a third type of 5cr-R (Lephart, 1993), which, how-
ever, has not been cloned so far.
Figure 3 shows the autoradiography obtained after
Southern analysis on the amplification products of the
RT-PCR for type 1 or type 2 5a-R performed on the
RNAs of the different cultures of brain cells. A specific
transcript of the type 1 5a-R (upper panel) is detect-
able in RNA samples obtained from the mixed glia
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(lane 2), type 1 astrocytes (lane 3), oligodendrocytes
(lane 4), and neurons (lane 5); the amplification prod-
ucts correspond in size to those observed in the rat
prostate (lane 6) and in the rat abdominal skin (lane
7), used as positive controls. Lane 1 corresponds to
the DNA markers, whereas lane 8 corresponds to the
blank, in which no total RNA was added. No specific
amplification products for the type 2 isoform (Fig. 3,
lower panel) have been observed after the RT-PCR of
the same samples tested for the type 1 isozyme (lanes
2—5), even after prolonged exposure of the membrane
to x-ray film (data not shown). A specific band of
hybridization of the expected size (279 bp) is amplified
from the mRNAs of the two control tissues (lanes 6
and 7). These data indicate that, in the present experi-
mental conditions, neither glial cells nor neurons are
able to express the type 2 5cr-R gene. Even if RT-PCR
is not a quantitative technique, it is interesting to note
that the signal obtained in lane 5 (neurons) is almost
two to three times higher (as evaluated by measuring
the optic density of the corresponding spots; data not
shown) than that obtained for glial cells, suggesting
that, among brain cells, the neurons are those express-
ing the highest levels of type 1 Scr-R. These data con-
firm and extend those previously reported by this labo-
ratory (Celotti et al., 1992; Melcangi et al., 1993), in
which a much higher Scr-R activity, as measured using
aradioenzymatic procedure, was found in fetal neurons
than in any type of neonatal glial cells. Pelletier et al.
(1994) have reported results that apparently conflict
with those described here. In fact, these authors failed
to detect any 5a-R immunoreactivity in the neuronal
component of the rat brain using an antibody raised
against the human type 1 Scr-R; in their study, the
material with the highest level of immunoreactivity
was diffusely distributed throughout the cytoplasm of
glial and ependymal cells. Possible explanations for
this discrepancy may reside in several facts. First, the
data presented here have been obtained by measuring
the actual activity of the enzyme as well as its gene
expression; in contrast, Pelletier et al. (1994) used
only a morphological approach for “quantifying” the
enzymatic protein. Moreover, the observations of Pel-
letier et al. (1994) were performed using an antibody
raised against a synthetic peptide reproducing the se-
quence of the human type 1 5cr-R, which is only par-
tially conserved in the corresponding rat isoform (Nor-
mington and Russell, 1992; Pelletier et al., 1994); con-
sequently, the possibility of a nonspecific reaction
cannot be excluded, especially because the authors
have not provided evidence on the efficiency of the
antibody toward the rat isozyme.
The presence of the type 1 5cr-R gene expression
and functional enzyme in all cells obtained from the
fetal or perinatal rat CNS, and reported in the present
study, agrees with a recent observation performed us-
ing in situ hybridization. In these studies the presence
of the mRNA for this isoform in specific regions of
the brain at different stages of development (Lauber
and Lichtensteiger, 1996) has been analyzed. These
data have shown that type 1 Scr-R mRNA is already
expressed in early stages of fetal development (the
first results were recorded on gestational day 12) and
is maximal in the proliferating zones close to the ven-
tricularwall. With the increase of the ageof the animal,
a substantially different localization was observed: the
expression of the enzyme is especially elevated in the
pyramidal cell layer of the hippocampus, in the subicu-
lum, in the cortical plate, in the thalamus, and in the
cerebellum at postnatal day 6. It is interesting that at
later intervals until adulthood, the level of the mRNA
of the type 1 isoform is in contrast elevated in white
matter structures, such as the optic chiasma, the corpus
callosum, etc. Also, this result agrees with previous
data of our laboratory (Poletti et al., 1990; Celotti
et al., 1992). During the late (postnatal) stages of
ontogeny, 5a-R enzyme expression appears to parallel
the process of myelinization (Celotti et al., 1992).
The expression of Aro in the different cell types of
the brain was also investigated using RT-PCR. In these
experiments, in addition to neurons of total fetal rat
brain (gestational day 15), also those obtained from
the hypothalamic region of the fetal rat brain (which
are known to possess the highest Aro activity) at gesta-
tional day 16 were analyzed. Figure 4 shows the South-
ern analysis performed on the amplified products ob-
tained with the RT-PCR technique. The rat ovary has
been used as a positive control (lane 7), whereas the
rat placenta, a tissue devoid of Aro mRNA, has been
used as a negative control (lane 8). As shown in Fig.
4, mixed glia (lane 2), type I astrocytes (lane 3),
and oligodendrocytes (lane 4) do not contain any Aro
transcripts. In contrast, in the mRNA samples of total
brain neurons, and especially of hypothalamic neurons,
a specific amplification product of the expected size
was present in correspondence to that obtained from
the rat ovary, indicating that the Aro gene is expressed
only in neurons and is probably particularly expressed
in those derived from the hypothalamus.
The specific localization of Aro in neurons and not
FIG. 4. Southern analysis performed on the RT-PCR product of
amplification obtained using specific sets ofoligoprimers for Aro.
The amplification was performed on the total RNAderived from
the following samples: lane 1, DNA markers; lane 2, mixed glial
cells; lane 3, type 1 astrocytes; lane 4, oligodendrocytes; lane
5, neurons derived from the whole brain; lane 6, neurons derived
from the hypothalamic area; lane 7, rat ovary in estrus; lane 8,
rat placenta; and lane 9, water.
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in glial cells has been previously described by immu-
nohistochemical (Shinoda, 1994) and in situ hybrid-
ization (Lauber and Lichtensteiger, 1994) techniques
and, in our laboratory, by a more direct approach, i.e.,
via the evaluation of the Aro activity in primary cul-
tures of different brain cell populations (neuronal and
glial cells) (Negri-Cesi et al., 1992). However, the
Aro and its expression were recently found by in situ
hybridization analysis, northern blot analysis, and mea-
surement of the enzymatic activity in enriched glial cell
cultures of the developing zebra finch telencephalon
(Schlinger et al., 1994). It is obvious that a species
difference may be responsible for this apparent dis-
crepancy, as the zebra finch is a nonmammalian spe-
cies.
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